Senior Journalist - China Biotech

Dragonfly Therapeutics·
Remote
2mo ago
Full-timeSeniorEditorial
Market Rate — Computer User Support Specialists
25th
$45K
Median
$58K
75th
$74K

BLS 2024 data (national)

Description

<meta><h2 style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;line-height:1.6;font-size:15pt;font-weight:600;letter-spacing:0.5px;margin-top:18px;margin-bottom:4px;padding-left:0px;"><span style="font-size:17pt;white-space:pre-wrap;">The Opportunity</span></h2><p style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:11pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;"><i><em style="color:rgb(0,0,0);font-size:11pt;white-space:pre-wrap;">Endpoints News</em></i><span style="color:rgb(0,0,0);font-size:11pt;white-space:pre-wrap;"> is seeking a senior journalist who can help build our coverage of China’s booming biopharma industry. This is a role for a journalist who wants to set the agenda on one of biotech’s most important stories, and is interested in playing a crucial role expanding our coverage in the region.&nbsp;</span></p><p style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:11pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;"><br></p><p style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:11pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;"><span style="color:rgb(0,0,0);font-size:11pt;white-space:pre-wrap;">In this role, you’ll cover Chinese biotechs including R&amp;D work, public and private financial markets, and key industry power players. You’ll work closely with our team in the US to help readers understand how the US and China compete and cooperate. And you’ll help uncover cool startups, interesting science, and new entrepreneurs.</span></p><p style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:11pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;"><br></p><p style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:11pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;"><span style="color:rgb(0,0,0);font-size:11pt;white-space:pre-wrap;">This is the first of several roles in the region that we hope to hire, as part of our growing coverage of China’s role in global biotech and how it serves its own citizens and interacts with the rest of the world.</span></p><p style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:11pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;"><br></p><p style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:11pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;"><span style="color:rgb(0,0,0);font-size:11pt;white-space:pre-wrap;">The right candidate has a clearly articulated point of view on the biotech industry, experience reporting in China, is a strong writer or editor, and is ready and able to work with our colleagues in the US and UK as a team player. We plan to eventually hire more staff in the region, and we’re looking for somebody who can lead by example, and eventually help manage a team. You’ll have the opportunity to shape our coverage and our regional footprint, help hire additional resources in the region, and will have a high-impact, high-profile role at Endpoints.</span></p><p style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:11pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;"><br></p><h4 style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;line-height:1.6;font-size:18pt;font-weight:600;letter-spacing:0px;margin-top:12px;margin-bottom:4px;padding-left:0px;"><span style="color:rgb(0,0,0);white-space:pre-wrap;">Key attributes:&nbsp;</span></h4><ul data-pattern="discCircleSquare" data-depth="1" style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:11pt;font-weight:400;margin:8px 0px;line-height:1.6;padding:0px 0px 0px 32px;list-style-type:disc;"><li style="font-size:11pt;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;"><span style="color:rgb(0,0,0);font-size:11pt;white-space:pre-wrap;">7+ years experience in business journalism; including experience covering business and biopharma</span></li><li style="font-size:11pt;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;"><span style="color:rgb(0,0,0);font-size:11pt;white-space:pre-wrap;">Excellent written and spoken English, plus Mandarin language skills&nbsp;&nbsp;</span></li><li style="color:rgb(0,0,0);font-size:11pt;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;"><span style="color:rgb(0,0,0);font-size:11pt;white-space:pre-wrap;">Located in or willing to relocate to Hong Kong, able to travel to mainland China</span></li><li style="color:rgb(0,0,0);font-size:11pt;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;"><span style="color:rgb(0,0,0);font-size:11pt;white-space:pre-wrap;">Collaborative, entrepreneurial attitude</span></li></ul><h4 style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;line-height:1.6;font-size:18pt;font-weight:600;letter-spacing:0px;margin-top:12px;margin-bottom:4px;padding-left:0px;"><br><span style="white-space:pre-wrap;">Why Join Us?</span></h4><p style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:11pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;"><span style="font-size:10pt;white-space:pre-wrap;">🌍&nbsp;</span><b><strong style="font-size:10pt;white-space:pre-wrap;">Work From Anywhere!</strong></b></p><p style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:11.25pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;"><b><strong style="font-size:10pt;white-space:pre-wrap;">👥 Positive, Supportive, and Collaborative Work Culture.</strong></b></p><p style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:11.25pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;"><span style="font-size:10pt;white-space:pre-wrap;">🌴&nbsp;</span><b><strong style="font-size:10pt;white-space:pre-wrap;">Enhanced Annual Leave</strong></b><span style="font-size:10pt;white-space:pre-wrap;">.</span></p><p style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:11.25pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;"><span style="font-size:10pt;white-space:pre-wrap;">🩺</span><b><strong style="font-size:10pt;white-space:pre-wrap;"> Healthcare Scheme</strong></b><span style="font-size:10pt;white-space:pre-wrap;">: Private medical insurance offered to you and your family (spouse/partner and children).</span></p><p style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:11.25pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;"><span style="font-size:10pt;white-space:pre-wrap;">🦷</span><span style="font-size:11pt;white-space:pre-wrap;">&nbsp;</span><b><strong style="font-size:10pt;white-space:pre-wrap;">Dental Scheme and Eye Care</strong></b><span style="font-size:10pt;white-space:pre-wrap;">.</span></p><p style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:10pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;"><span style="color:rgb(0,0,0);font-size:10pt;white-space:pre-wrap;">💸&nbsp;</span><b><strong style="color:rgb(0,0,0);font-size:10pt;white-space:pre-wrap;">Pension Scheme</strong></b></p><p style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:10pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;"><span style="color:rgb(0,0,0);font-size:10pt;white-space:pre-wrap;">📁&nbsp;</span><b><strong style="color:rgb(0,0,0);font-size:10pt;white-space:pre-wrap;">Life Insurance</strong></b><span style="color:rgb(0,0,0);font-size:10pt;white-space:pre-wrap;">.</span></p><p style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:11.25pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;"><span style="font-size:10pt;white-space:pre-wrap;">👪&nbsp;G</span><b><strong style="font-size:10pt;white-space:pre-wrap;">lobal Paid Parental Leave</strong></b><span style="font-size:10pt;white-space:pre-wrap;">: This includes 20 weeks maternity leave and 12 weeks paternity leave.</span></p><p style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:11.25pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;"><span style="font-size:10pt;white-space:pre-wrap;">💪&nbsp;</span><b><strong style="font-size:10pt;white-space:pre-wrap;">Paid Volunteer Days:&nbsp;</strong></b><span style="font-size:10pt;white-space:pre-wrap;">Provides employees with the opportunity to engage in community service &amp; volunteer activities.</span></p><p style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:11.25pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;"><span style="font-size:10pt;white-space:pre-wrap;">💻&nbsp;</span><b><strong style="font-size:10pt;white-space:pre-wrap;">Equipment Provided:&nbsp;</strong></b><span style="font-size:10pt;white-space:pre-wrap;">Laptop, monitor, and additional equipment needs.</span></p><p style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:11.25pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;"><br></p><p style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:11.25pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;"><i><em style="font-size:7.5pt;white-space:pre-wrap;">Endpoints News is an equal opportunity employer. We celebrate diverse backgrounds and thoughts and welcome everyone to apply for employment with us. We are committed to fostering an environment that is inclusive, transparent, and collaborative. Mutual respect is central to how Endpoints News operates, and we believe the best solutions come from diverse perspectives, experiences, and skills. We embrace our differences and know that we are stronger working together.</em></i></p><p style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:11.25pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;"><br></p> <meta><p style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:11.25pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;"><b><strong style="font-size:18pt;white-space:pre-wrap;">About Endpoints News Media Company, LLC</strong></b></p><p style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:11.25pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;"><span style="font-size:12pt;white-space:pre-wrap;">Endpoints News is a media company covering the most critical developments for leaders across the biopharma world. Launched in 2016, Endpoints News has become the way drug development executives stay informed. Reported by a global team of journalists — led by co-founder John Carroll &amp; Executive Editor Drew Armstrong — Endpoints covers news as it happens and delivers an inimitable twice-daily email report to an engaged audience in the business of discovering, researching, marketing, and regulating biotech drugs. In April, 2023, the Financial Times took a controlling stake in Endpoints News.</span></p><p style="font-family:&quot;Basel Grotesk&quot;,Arial,sans-serif;font-size:11.25pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;"><span style="font-size:12pt;white-space:pre-wrap;">The Financial Times is one of the world’s leading business news organizations, recognised internationally for its authority, integrity and accuracy. The FT has a record paying readership of 1.2 million, more than one million of which are digital subscriptions. It is part of Nikkei Inc., which provides a broad range of information, news and services for the global business community.</span></p>
DT

Dragonfly Therapeutics

BIOTECHNOLOGY

Immuno-oncology Drugs

LocationMA - Waltham
Open Jobs1
Oncology
View Company Profile

Pipeline

Elecsys semi-quantitative Anti-SARS-CoV-2 antibody testN/A
DF6215Phase 1
DF5112Phase 1
DF6002Phase 1
DF9001Phase 1/2